The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets
| Field | Value | Language |
| dc.contributor.author | Black, Harrison | |
| dc.contributor.author | Xu, Wenbo | |
| dc.contributor.author | Hortle, Elinor | |
| dc.contributor.author | Robertson, Sonia | |
| dc.contributor.author | Britton, Warwick | |
| dc.contributor.author | Kaur, Amandeep | |
| dc.contributor.author | New, Elizabeth | |
| dc.contributor.author | Witting, Paul | |
| dc.contributor.author | Chami, Belal | |
| dc.contributor.author | Oehlers, Stefan | |
| dc.date.accessioned | 2020-02-12 | |
| dc.date.available | 2020-02-12 | |
| dc.date.issued | 2019-05-01 | |
| dc.identifier.citation | Black, H. D., Xu, W., Hortle, E., Robertson, S. I., Britton, W. J., Kaur, A., … Oehlers, S. H. (2019). The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets. Free Radical Biology and Medicine, 135, 157–166. https://doi.org/10.1016/j.freeradbiomed.2019.03.010 | en |
| dc.identifier.uri | https://hdl.handle.net/2123/21834 | |
| dc.description.abstract | Tuberculosis is a chronic inflammatory disease caused by persistent infection with Mycobacterium tuberculosis. The rise of antibiotic resistant strains necessitates the design of novel treatments. Recent evidence shows that not only is M. tuberculosis highly resistant to oxidative killing, it also co-opts host oxidant production to induce phagocyte death facilitating bacterial dissemination. We have targeted this redox environment with the cyclic nitroxide derivative 4-methoxy-TEMPO (MetT) in the zebrafish-M. marinum infection model. MetT inhibited the production of mitochondrial ROS and decreased infection-induced cell death to aid containment of infection. We identify a second mechanism of action whereby stress conditions, including hypoxia, found in the infection microenvironment appear to sensitise M. marinum to killing by MetT both in vitro and in vivo. Together, our study demonstrates MetT inhibited the growth and dissemination of M. marinum through host and bacterial targets. | en |
| dc.description.sponsorship | This work was supported by the Australian National Health and Medical Research Council grants APP1099912 and APP1053407; The University of Sydney, Australia Fellowship G197581; NSW Ministry of Health, Australia under the NSW Health Early-Mid Career Fellowships Scheme H18/31086; and the Kenyon Family Inflammation Award (S.H.O.). | en |
| dc.language.iso | en | en |
| dc.publisher | Elsevier | en |
| dc.relation | NHMRC APP1053407 and APP1099912 | en |
| dc.rights | Other | |
| dc.subject | Antioxidant | en |
| dc.subject | Cell death | en |
| dc.subject | Host-directed therapy | en |
| dc.subject | Hypoxia | en |
| dc.subject | Infection | en |
| dc.subject | Mitochondria | en |
| dc.subject | Zebrafish | en |
| dc.title | The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets | en |
| dc.type | Article | en |
| dc.subject.asrc | FoR::110707 - Innate Immunity | en |
| dc.subject.asrc | FoR::110801 - Medical Bacteriology | en |
| dc.identifier.doi | 10.1016/j.freeradbiomed.2019.03.010 | |
| dc.type.pubtype | Author accepted manuscript | en |
| usyd.faculty | Faculty of Medicine and Health, Sydney Medical School | en |
Associated file/s
Associated collections